Company
Headquarters: Nanjing, China
CN¥16.14 Billion
CNY as of Jan. 1, 2026
US$2.30 Billion
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Micro-Tech (Nanjing) Co., Ltd. manufactures and sells non-vascular stents and disposable biopsy forceps primarily in China, Europe, North America, Oceania, etc. The company offers gastroenterology products, such as biliary (longwire), biliary (shortwire), biopsy, dilation and hemostasis products, EUS, nitinol stents, resection products, retrieval devices, and accessories; and pulmonology products, such as airway stents, biopsy, dilation balloons, cytology brushes, retrieval devices, and accessories. The company also offers OEM/ODM services to companies in the medical devices field. Micro-Tech (Nanjing) Co., Ltd. was founded in 1999 and is based in Nanjing, China.
| Last Financial Reports Date | June 30, 2025 |
| Revenue TTM | CN¥3.12 B |
| EBITDA | CN¥794.1 M |
| Gross Profit TTM | CN¥1.99 B |
| Profit Margin | 19.57% |
| Operating Margin | 23.52% |
| Quarterly Revenue Growth | 20.10% |
Micro-Tech has the following listings and related stock indices.
Stock: SSE: 688029